Covalon Technologies Ltd. (Covalon) has appointed David McFaul to its board of directors. McFaul is currently senior vice-president of international at Boston Scientific Corporation (Boston Scientific). He has worked at Boston Scientific since 1995 and held numerous leadership positions in various international markets.
Brad Williams, chairman of the board, commented: “David McFaul is a results oriented executive with extensive experience in sales, marketing, and product development with major medical device companies who are leaders in their field. I worked with David for seven years when I was the head of Stryker Corporation’s Canadian Division, and he was instrumental in helping us build a world class team that led the field in the markets in which we competed. His experience in the medical device industry and his proven track record of success positions him well to help Covalon as it enters its next phase of growth.”
Frank DiCosmo, president & chief executive officer, said: “David adds valuable expertise to Covalon’s Board. Prior to his current role at Boston Scientific Corporation, he served as Regional President of Asia-Pacific & Japan operations. David was also Vice President of Sales, Inter-Continental, responsible for overall sales execution for the business. The role included training and developing more than 400 sales representatives and 85 sales managers in 35 countries. David brings tremendous experience to Covalon, having been involved in high-performance sales management programs as well as clinical training programs. David has also served as Vice President and General Manager in Latin America, Canada and South Africa where he increased revenue by almost 50%. He was also General Manager, Canada and South Africa, Country Manager of Canada and National Sales Manager, Canada. I first met David almost 10 years ago, and I am very pleased to now welcome David to Covalon’s Board of Directors.”